Press release content from Business Wire. The AP news staff was not involved in its creation.
Axion BioSystems Announces Formation of Scientific Advisory Board
April 20, 2021 GMT
ATLANTA (BUSINESS WIRE) Apr 20, 2021
Axion BioSystems, a leading life science tools company focused on developing and commercializing label-free, bioelectronic assays used to study the function of live cells
in vitro, announces the formation of a Scientific Advisory Board (SAB). The SAB will be chaired by Jim Ross, Ph.D., founder and Chief Technology Officer, and will work closely with Axion BioSystems’ management team to help identify and prioritize Axion’s next generation of bioelectronic products.
Dr Mitchell Morris Named eMed Chief Operating Officer
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Dr Mitchell Morris Named eMed Chief Operating Officer
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Title Text:
Caption:
Description:
Image Credit:
Submitted
City University of New York Chancellor Félix Matos Rodríguez has followed through on increasing faculty diversity. Nine new college presidents – including two Asian Americans, three African Americans and three women – were appointed in the past year. Early on in the COVID-19 pandemic, CUNY established the Chancellor’s Emergency Relief Fund with $1 million each from the Carroll and Milton Petrie Foundation and the James and Judith K. Dimon Foundation. This grew to more than $8 million by the fall and allowed CUNY to distribute emergency grants to more than 10,000 students.
2. Jim Malatras
SUNY Empire State College
Novel Drug Regenerates Erectile Nerves Damaged by Prostate Surgery
News provided by
Share this article
Share this article
BRONX, N.Y., April 19, 2021 /PRNewswire/ Researchers at Albert Einstein College of Medicine have developed a topical drug that regenerates and restores the function of erectile nerves damaged by radical prostatectomy, the most common treatment for localized prostate cancer. The drug was tested in rats, and the findings were published online today in
JCI Insight.
These images show neurons cultured in petri dishes and treated with either control (inactive) siRNA (left) or the siRNA drug itself (FL2 siRNA) (right). Neurons treated with the drug regenerate their axons (the thin fibers extending from the neurons central bodies) at a significantly faster rate than control-treated neurons. Scale bar = 0.10 mm.